Corneal Epithelial Defect Market Size, Industry Analysis, Epidemiology, Pipeline Therapies And Key Companies By DelveInsight
Corneal epithelial defects are focal areas of epithelial (outermost corneal layer) loss; they can be due to mechanical trauma, corneal dryness, neurotrophic disease, post surgical changes, infection, or any other of a variety of etiologies.
DelveInsight's Corneal
Epithelial Defect Market
Insights report provides a thorough understanding of current treatment
practices, emerging drugs, Corneal Epithelial Defect market share of the
individual therapies, current and forecasted Corneal Epithelial Defect market
size from 2018 to 2030 segmented into 7MM (the USA, EU5 (the UK, Italy, Spain,
France, and Germany), and Japan).
Some facts of Corneal
Epithelial Defect Market Report:
·
Corneal Epithelial Defect Market size is
expected to change for 7MM during the forecast period of 2018-30.
·
The key driver for the surge in market size is
the rise in number of incident cases.
·
As per the study conducted by Wirostko et al. titled
“Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth
Hormone” stated that the estimated number of PCEDs per year in the United
States is roughly 73,434−99,465 cases, based on a recent US population of
approximately 314,037,169. The total incidence of PCEDs is less than 200,000 in
the US, and is therefore considered an orphan disease in this region.
·
Abdel‐Naby et al. conducted a study titled
“Silk‐Derived Protein Enhances Corneal Epithelial Migration, Adhesion, and
Proliferation” mentioned that annually, over 50 million people worldwide suffer
from blindness as a result of corneal disease with nearly 2.5 million new eye
injuries occurring each year in the United States.
·
According to a study conducted by Chen et al. titled
“Corneal persistent epithelial defect after pars plana vitrectomy” wherein the results
showed that postoperative corneal complications developed in 103 of 460 (22.4%)
eyes. Among 103 eyes with corneal complications, 21 eyes developed PCED. The eyes
with PCED had poor final visual acuity, with 23.8% of the eyes in the PCED
group having visual acuity of 20 per 200 or better compared with 51.2% of the
eyes in the non‐PCED group.
To get more detailed
insight on Corneal Epithelial Defect Market Report @Request for a Sample Report
here: https://www.delveinsight.com/sample-request/corneal-epithelial-defect-market
View Report: https://www.delveinsight.com/report-store/corneal-epithelial-defect-market
Scope of Corneal
Epithelial Defect Market Report:
·
The report covers the descriptive overview of Corneal
Epithelial Defect, explaining its causes, signs and symptoms, pathophysiology,
diagnosis and currently available therapies
·
Comprehensive insight has been provided into the
Corneal Epithelial Defect epidemiology and treatment in the 7MM
·
Additionally, an all-inclusive account of both
the current and emerging therapies for Corneal Epithelial Defect are provided,
along with the assessment of new therapies, which will have an impact on the
current treatment landscape
·
A detailed review of Corneal Epithelial Defect
market; historical and forecasted is included in the report, covering drug
outreach in the 7MM
·
The report provides an edge while developing
business strategies, by understanding trends shaping and driving the global Corneal
Epithelial Defect market
Some of Corneal
Epithelial Defect Companies are:
·
Noveome Biotherapeutics
·
Santen Pharmaceutical
·
Eyegate Pharma
·
And Many Others
To get more detailed
insight on Corneal Epithelial Defect Key Players @Request for a Sample Report
here: https://www.delveinsight.com/sample-request/corneal-epithelial-defect-market
View Report: https://www.delveinsight.com/report-store/corneal-epithelial-defect-market
Corneal
Epithelial Defect Therapies
are:
·
ST266
·
DE‐105
·
Ocular bandage gel
(OBG)
·
And Many Others
To get more detailed insight
about Corneal Epithelial Defect Therapies @Request for a Sample Report here: https://www.delveinsight.com/sample-request/corneal-epithelial-defect-market
Table of Contents:
1. Key Insights
2. Executive Summary of Corneal Epithelial Defect
3. Competitive Intelligence Analysis for Corneal Epithelial
Defect
4. Corneal Epithelial Defect: Market Overview at a Glance
4.1. Corneal Epithelial Defect Total Market Share (%)
Distribution in 2017
4.2. Corneal Epithelial Defect Total Market Share (%)
Distribution in 2030
5. Corneal Epithelial Defect: Disease Background and
Overview
6. Patient Journey
7. Corneal Epithelial Defect Epidemiology and Patient
Population
8. Treatment Algorithm, Current Treatment, and Medical
Practices
8.1. Corneal Epithelial Defect Treatment and Management
8.2. Corneal Epithelial Defect Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Corneal Epithelial Defect Treatment
11. Marketed Products
12. Emerging Therapies
13. Corneal Epithelial Defect: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Corneal Epithelial
Defect
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
View Report: https://www.delveinsight.com/report-store/corneal-epithelial-defect-market
DelveInsght’s Competitive
Intelligence Service includes a multidimensional coverage,
helping to keep track of competitors and gain traction in the dynamic market by
overcoming the challenges and expediting business growth through a strategic
and tactical approach.
Related Reports:
- Thymic
Carcinoma Market
- Asphyxia
Market
- Acute
Agitation And Aggression Market
- HPV-Induced
Cancers Market
- Diagnostic
Imaging Equipment Market
- Epilepsy
Market
- Bradykinesia
Market
- Immunologic
Deficiency Syndrome Market
- Wilms
Tumor Market
- Advanced
Wound Care Market
- Defibrillators
Market
- Diagnostic
Imaging Equipment Market
- Pulse
Oximeters Market
- Achromatopsia
Market
- Cataplexy
Market
Related Blogs:
- Social
Determinants of Health and their Impact on COVID-19
- Top
Drugs To Watch in HIV (2025)
- Gene
Therapy for Hemophilia: Progress and Setbacks
- IgA
Nephropathy – In-depth Assessment of the Emerging Therapies and Key
Companies in the Therapeutics Domain
- Smart
Hospital: How it is Shaping the Future of Healthcare Delivery
- An
in-depth Assessment of the Top Drugs Launched by Leading Global Companies
in 2021
About Delveinsight:
DelveInsight Business Research is a leading Market
Research, and Business Consultant focused purely on Healthcare. It
helps pharma companies by providing them with end-to-end services to solve
their business problems.
Get hold of all the Pharma and healthcare market research
reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment